INTRODUCTION
============

Given the extensive use of antibiotics in intensive care units (ICUs) \[[@b1-acc-2018-00220]\], nosocomial infections with multidrug-resistant (MDR) pathogens in an ICU have become a major problem. In a previous prospective surveillance study of 10 Asian countries, resistance to imipenem was observed in 67.3% of *Acinetobacter* isolates and 27.2% of *Pseudomonas aeruginosa* isolates, with MDR rates of 82% and 42.8% among patients with hospital-acquired pneumonia and ventilator-associated pneumonia, respectively \[[@b2-acc-2018-00220]\]. The mortality rates of hospital-acquired pneumonia and ventilator-associated pneumonia are higher than those of community-acquired pneumonia and healthcare-associated pneumonia \[[@b3-acc-2018-00220]\]. Furthermore, MDR pathogens can increase the mortality rates of ICU-acquired pneumonia \[[@b4-acc-2018-00220]\]. Therefore, controlling the prevalence of MDR pathogens in the ICU is mandatory for patient safety.

Efforts have been made to decrease the risk of MDR pathogen transmission. Methods such as active surveillance cultures, room placement, cohorting, hand hygiene, use of clean gloves and gowns, and enforcing strict adherence to precautions have been used to decrease the incidence rates (IRs) of MDR pathogen infections \[[@b5-acc-2018-00220]-[@b7-acc-2018-00220]\]. However, all those precautions focus on person-to-person transmission. The importance of environmental contamination is not well understood. In the present study, we elucidate the effects of an environmental change, the relocation of a medical ICU (MICU), on respiratory MDR microorganisms in the ICU.

MATERIALS AND METHODS
=====================

Study Population and Clinical Characteristics
---------------------------------------------

Between November 2016 and July 2017, patients admitted to the MICU in a tertiary referral center in Seoul National University Hospital were screened. All adult patients (≥18 years) were included. Because of a remodel of the center's MICU, patients had to be moved to a newly-built temporary MICU on the 8th of March, 2017. Prior to its relocation, the MICU had 20 open beds and two isolation beds, and the average space was 19.7 m^2^ per patient. Among the 20 open beds, four belonged to the Department of Neurology and were excluded from the analysis. After its relocation, the MICU had 12 open beds with two isolation beds, all of which belonged to the Department of Internal Medicine, and the average space was 21.7 m^2^ per patient.

Patients were retrospectively analyzed in terms of baseline demographics (sex, age, underlying comorbidities, and Acute Physiology and Chronic Health Evaluation \[APACHE\] II scores) before and after the relocation. The use of medications with potential effects on respiratory microbiota, such as antacids and steroids, and antibiotic use were also reviewed. As clinical outcomes, we compared the use of antibiotics, length of MICU stay, length of hospital stay, and in-hospital mortality. Days of medication use and ventilator use were calculated in calendar days.

This study was conducted in accordance with the amended Declaration of Helsinki and was approved by the Institutional Review Board of Seoul National University Hospital (protocol no. H-1705-019-851). The requirement for informed consent was waived because of the retrospective study design and because all patients records and information were anonymized prior to analysis.

Microbiological Evaluation
--------------------------

To maximize the sensitivity of respiratory microbiome detection, several respiratory specimen culture results were reviewed. Noninvasive respiratory specimens from sputum and endotracheal aspirate, along with invasive respiratory specimens such as bronchial washings and bronchoalveolar lavage fluids were included. Sputum was collected in a sterile conical tube after coughing effort from the patient, and endotracheal aspiration was performed by the attending nurse with a sterile catheter and saline. Bronchoscopic specimens were collected by a board-certified pulmonary specialist with a sterile bronchoscope and saline. Active surveillance cultures of carbapenem-resistant *Acinetobacter baumannii* (CRAB) were routinely performed from sputum or endotracheal aspirate specimens upon MICU admission and were also included in the analysis. CRAB, methicillin-resistant *Staphylococcus aureus* (MRSA), carbapenem-resistant *Pseudomonas aeruginosa* (CRPA), extended-spectrum β-lactamase (ESBL)-producing Gram-negative *Enterobacteriaceae*, and *Stenotrophomonas maltophilia* were considered as the MDR pathogens \[[@b8-acc-2018-00220],[@b9-acc-2018-00220]\]. The IR of MDR respiratory pathogens was compared before and after the relocation and also described monthly. The microorganisms were considered to be MICU-acquired if they were first detected after MICU admission, or if they first appeared after 3 days of MICU stay.

Standard Precautions in the MICU
--------------------------------

Isolation beds were isolated with walls and a door, whereas open beds were divided by curtains. The patient to nurse ratio was 2:1 during the day and evening and 3:1 at night. Routine cleaning of the floors was performed every day with 4% sodium hypochlorite and was done more frequently when visual contamination was observed. When a patient left the ICU bed, every surface of the patient's medical equipment was cleaned with 50% benzalkonium chloride.

Medical professionals were required to wash their hands with soap and water and with 0.5% chlorhexidine gluconate in 70% or 83% ethanol before and after attending a patient. If any MDR microorganism was detected in a patient, wearing clean nonsterile gloves and gowns was obligatory while attending to that patient. Also, separate items such as thermometers, stethoscopes, tourniquets, and blood pressure cuffs were used. Adherence to those precautions was monitored on a weekly basis, and the precaution protocols did not change before and after the MICU relocation.

Statistical Analysis
--------------------

Categorical variables are described as numbers and percentages and compared using either the chi-square test or Fisher exact test. Numerical variables are described using the median and interquartile range (IQR) and compared using the Mann-Whitney *U*-test. IRs are described as numbers per 1,000 patient-days with 95% confidence intervals (CIs) and compared using Poisson regression analyses or negative binomial regression analyses. All statistical analyses were performed using STATA version 13.0 (Stata Corp., College Station, TX, USA). The P-values of less than 0.05 were considered statistically significant.

RESULTS
=======

Baseline Characteristics
------------------------

A total of 463 patients were admitted to the MICU during the study period. Among them, 234 patients were admitted to the MICU before its relocation, and the other 229 were admitted afterward. Patients were predominantly male (65%), with a median age of 66 years (IQR, 58 to 74 years) and a median APACHE II score of 28 (IQR, 19 to 36). Among the 463 patients, 108 (23.3%) were diagnosed with sepsis, and 155 (33.5%) were diagnosed with pneumonia. The prevalence of sepsis increased significantly after the MICU relocation (18.8% to 28.0%, P=0.020). The most common underlying comorbidity was hematologic malignancy (21.8%), followed by solid organ malignancy (19.7%), diabetes mellitus (13.4%), heart failure (10.8%), end-stage renal disease (9.7%), liver cirrhosis (6.1%), solid organ transplant (5.6%), and bronchiectasis (3.5%). The proportion of patients who were transferred from other ICUs was 18.8%, which did not differ before and after the relocation (P=0.333). Antacids were administered to 87.7% of patients. Mechanical ventilation was administered to 67.8% of patients for a median of 4 days (IQR, 2 to 9 days), and ventilator dependency (ventilator use ≥21 days) was observed in 43 of 483 patients (8.9%), which did not differ before and after the MICU relocation (5.1% vs. 4.8%, P=0.872). Steroids were administered to 54.2% of patients for a median of 4 days (IQR, 2 to 8 days). These baseline characteristics did not differ between the before and after MICU relocation groups. A total of 530.5 respiratory samples (95% CI, 488.2 to 572.8) were used to perform microbiological analyses per 1,000 patient-days before the relocation, and 513.5 samples (95% CI, 468.6 to 558.5) were used per 1,000 patientdays after the relocation, and that difference was not statistically significant (P=0.558) ([Table 1](#t1-acc-2018-00220){ref-type="table"}).

Changes in the MDR Respiratory Microorganisms
---------------------------------------------

The IR of MDR respiratory microorganism infections decreased from 90.0 to 68.8 per 1,000 patient-days after the MICU relocation, but that difference was not statistically significant (P=0.349). The IR of CRAB decreased from 49.2 to 30.7 per 1,000 patientdays (P=0.252), and the IR of MICU-acquired CRAB decreased from 32.5 to 26.8 per 1,000 patient-days (P=0.673). The IR of MRSA decreased from 25.6 to 19.0 per 1,000 patient-days (P=0.530), and the IR of MICU-acquired MRSA decreased from 18.2 to 10.1 per 1,000 patient-days (P=0.337). Changes in other MDR respiratory microorganisms, including *S. maltophilia*, ESBL-producing gram-negative *Enterobacteriaceae*, and CRPA, were also not statistically significant ([Figure 1](#f1-acc-2018-00220){ref-type="fig"}).

Patients with sepsis and pneumonia were analyzed separately, but the results were similar. In patients with sepsis, the IR of all MDR pathogens decreased from 103.6 to 82.8 per 1,000 patient-days (P=0.672), and the IR of CRAB decreased from 87.8 to 35.5 per 1,000 patient-days (P=0.164), both lacking statistical significances. Among patients diagnosed with pneumonia, the IRs were similar: all MDR pathogens stayed the same (86.0 to 86.0 per 1,000 patient-days, P=0.992), and CRAB decreased without significance (51.9 to 48.2 per 1,000 patient-days, P=0.909).

The monthly IRs of MDR respiratory microorganisms were specified to further assess the effect of the MICU relocation. In contrast to a high IR of MDR respiratory microorganisms in February 2017 (125.9 per 1,000 patient-days), the IR in March 2017, the month in which the relocation of the MICU occurred, decreased to 70.5 per 1,000 patient-days. The IR further decreased to 33.8 per 1,000 patient-days in May 2017, and the difference between February 2017 and May 2017 was statistically significant (P=0.022) ([Figure 2](#f2-acc-2018-00220){ref-type="fig"}). However, the IR rose again to 149.8 per 1,000 patient-days in June 2017, when 16 of 43 patients (37.2%) were diagnosed with at least one detectable MDR pathogen. This detection rate was significantly higher than that observed for the other months, including April (3/44 patients, 6.8%) and May (6/55 patients, 10.9%). High rates of CRAB (7/43 patients, 16.3%) and MRSA (5/43 patients, 11.6%) detection were the main factors contributing to the increase in MDR microorganisms. Other than CRAB and MRSA, CRPA (two patients), and ESBL-producing gram-negative *Enterobacteriaceae* (two patients) were also detected in June 2017.

Changes in Antibiotic Use
-------------------------

We reviewed the most commonly used antibiotics and found that carbapenem was most often used, for 275.7 days per 1,000 patient-days before the relocation and 267.8 days after the relocation (P=0.827). The use of other antibiotics, piperacillin/tazobactam (229.7 vs. 208.2 days per 1,000 patient-days, P=0.547), quinolone (229.2 vs. 213.5 days per 1,000 patient-days, P=0.682), glycopeptide (133 vs. 164.1 days per 1,000 patient-days, P=0.225), and linezolid (21.6 vs. 19.6 days per 1,000 patient-days, P=0.893), did not differ significantly according to the MICU relocation. However, the use of colistin decreased significantly from 53.5 days (95% CI, 20.3 to 86.7 days) to 18.7 days (95% CI, 5.6 to 31.7 days) per 1,000 patient-days (P=0.027) ([Figure 3](#f3-acc-2018-00220){ref-type="fig"}).

Differences in Clinical Outcomes
--------------------------------

We compared the clinical outcomes before and after the MICU relocation. Among the 463 patients included in the study, the overall in-hospital mortality rate was 51.8%. The median length of MICU stay was 5 days (IQR, 2 to 9 days), and the median length of hospital stay was 25 days (IQR, 12 to 46 days). The length of MICU stay (median, 6 vs. 5 days, P=0.145) and inhospital mortality (52.5% vs. 47.5%, P=0.382) did not differ significantly between the two groups. However, the length of hospital stay was shortened after the relocation from a median of 29 days (IQR, 14 to 50 days) to a median of 21 days (IQR, 11 to 39 days), which was statistically significant (P=0.001) ([Table 2](#t2-acc-2018-00220){ref-type="table"}).

DISCUSSION
==========

In this retrospective, single-center study, relocation of the MICU led to nonsignificant changes in the IR of MDR respiratory microorganisms, including CRAB and MRSA. However, the use of colistin was significantly reduced, and the length of hospital stay was shortened. This is the first study to describe the importance of environmental change to infections by MDR pathogens, including CRAB, one of the respiratory microorganisms most commonly found in ICUs.

The detection rate of MDR respiratory microorganisms and the use of antibiotics in our study are comparable with those reported in previous studies. In a prospective study from Spain \[[@b4-acc-2018-00220]\], the detection rate of MDR respiratory pathogens in ICU patients with pneumonia was 23.9%. In our study, 83 of 463 patients (17.9%) had at least one detectable MDR respiratory microorganism, and 34 of 155 patients with pneumonia (21.9%) had detectable MDR respiratory microorganisms. A prospective study from South Korea reported that the detection rate of CRAB in active surveillance cultures was 15% \[[@b10-acc-2018-00220]\]. In our study, CRAB was detected in 42 of 463 patients (9.1%). A prospective study from China reported MRSA incidence to be 13.9 cases per 100 ICU admissions \[[@b11-acc-2018-00220]\], and a retrospective study from Canada reported MRSA incidence to be 13.4--35.6 cases per 1,000 patient-days \[[@b12-acc-2018-00220]\]. Our study revealed 15.8 MRSA cases per 100 admissions (or 22.2 cases per 1,000 patient-days). The use of piperacillin/tazobactam, glycopeptide, and quinolone was similar to that reported in previous studies, but in our center, the use of carbapenem was higher and that of third-generation cephalosporin was lower than previously reported \[[@b11-acc-2018-00220],[@b13-acc-2018-00220]\].

Our results showed nonsignificant changes in the IR of MDR respiratory microorganisms after the relocation. The IR seemed to drop right after the relocation but increased again as time passed, especially in June 2017, when the IR of MDR respiratory microorganisms was the highest in our study period, mostly CRAB and MRSA. Although the exact reason for the sudden outbreak of CRAB and MRSA during June could not be clarified due to the study's retrospective design, some factors could be considered. Among the patients admitted to the MICU during June, a higher proportion were placed on mechanical ventilators (32/43 patients, 74.4%) than in other months (282/420 patients, 67.1%). The duration of ventilator application also tended to be slightly longer in June (mean, 7.3 days) than in the other months (mean, 6.9 days) although that difference was not statistically significant. The application of mechanical ventilators and more ventilator-days has previously been associated with a higher risk of MDR *Acinetobacter baumannii* colonization \[[@b14-acc-2018-00220]\]. Once colonization has been established, the next patient admitted to the same environment might have been exposed to an elevated risk of developing that infection, especially with *Acinetobacter* species \[[@b15-acc-2018-00220]\]. Furthermore, contamination of healthcare workers' protective gowns and gloves during routine management of patients can be frequent with *Acinetobacter* species and MRSA \[[@b16-acc-2018-00220]\]. Those factors could explain why the colonization rate of MDR microorganisms increased with time, even after relocation.

This study demonstrated a significant decrease in colistin use, despite a nonsignificant change in the IR of CRAB from respiratory specimens. This can be explained by the fact that CRAB is a common environmental colonizer \[[@b16-acc-2018-00220],[@b17-acc-2018-00220]\] and that *Acinetobacter* species are known to cause only 1.5% to 1.8% of the nosocomial infections caused by Gram-negative bacilli \[[@b18-acc-2018-00220]\]. It is therefore possible that a significant proportion of patients might have had CRAB "colonization" in their respiratory system rather an infection with "pathogenic" CRAB, resulting in a decrease in the use of colistin.

We also found a shortened hospital stay among patients after the MICU relocation. Because the baseline characteristics (age, sex, APACHE II score, and underlying disease) did not differ significantly before and after the relocation, this difference in clinical outcome could result from changes associated with the MICU relocation, including the reduced use of colistin. Several retrospective studies \[[@b19-acc-2018-00220],[@b20-acc-2018-00220]\] have reported that *Acinetobacter baumannii* infection is associated with a longer hospital stay. Inappropriate use of antibiotics during the initial days of a hospital-stay is known to be associated with longer hospital stays \[[@b21-acc-2018-00220]\], and that inappropriate use is most commonly associated with *Acinetobacter* species \[[@b22-acc-2018-00220]\]. Although mortality rates did not differ after the relocation in the present study, there are contradicting reports on differences in mortality rates according to *Acinetobacter* infections \[[@b19-acc-2018-00220],[@b20-acc-2018-00220],[@b23-acc-2018-00220],[@b24-acc-2018-00220]\]. The inconsistency between the duration of hospitalization and mortality rates could be caused by the low virulence of *Acinetobacter* species \[[@b25-acc-2018-00220]\].

This study has several limitations. First, this was a retrospective study from a single center. Information about recent antibiotics use, adequate antibiotics use, or a history of MDR infections could not be obtained. Second, it was difficult to discriminate between colonizers and pathogens due to the study's retrospective nature. Our results must be replicated in future prospective studies to be generalizable to other clinical settings. Third, due to the center's training curriculum, the annual turnover of resident doctors occurs in March. Therefore, resident doctors in February had nearly 2 years of practice as physicians, whereas those in March had only 1 year of practice and no experience as ICU doctors. That turnover might have affected the clinical outcomes after the MICU relocation \[[@b26-acc-2018-00220]\]. However, the number of MDR pathogens detected in the previous year did not reveal significant monthly variability ([Supplementary Table 1](#SD1-acc-2018-00220){ref-type="supplementary-material"}), which implies that the annual turnover of residents might not have affected the rates of MDR pathogen detection. Fourth, environmental sampling of the MICU before and after the relocation was not conducted. Collecting that information in future studies could support our results.

In conclusion, the IR of MDR respiratory microorganisms seemed to decrease after the MICU relocation but then increased in subsequent months, thereby leading to a nonsignificant difference in the 4-month IR before and after the relocation. Nonetheless, the use of colistin use was significantly reduced. Although a difference in overall mortality was not observed, length of hospital stay was shortened. Our findings emphasize the importance of environmental contamination control, especially for CRAB.

KEY MESSAGES
============

▪ Multi-drug resistant respiratory pathogens tended to decrease after relocation of the intensive care unit, although without statistical significance.

▪ Use of colistin was significantly reduced after the relocation.

▪ Duration of hospital stay was shorter after the relocation.
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SUPPLEMENTARY MATERIALS
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The online-only Supplement data are available with this article online: <https://doi.org/10.4266/acc.2018.00220>.
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###### 

Baseline characteristics of 463 patients admitted to the medical ICU before and after its relocation

  Variable                                                                     Before relocation (n=234)   After relocation (n=229)   P-value
  ---------------------------------------------------------------------------- --------------------------- -------------------------- ---------
  Male sex                                                                     154 (65.8)                  147 (64.2)                 0.715
  Age (yr)                                                                     67 (59--75)                 65 (57--74)                0.233
  APACHE II score                                                              27 (19--34)                 29 (19--38)                0.166
  Sepsis                                                                       44 (18.8)                   64 (28.0)                  0.020
  Pneumonia                                                                    69 (29.5)                   86 (37.6)                  0.066
  Underlying disease                                                                                                                  
   Hematologic malignancy                                                      45 (19.2)                   56 (24.5)                  0.174
   Solid organ malignancy                                                      46 (19.7)                   45 (19.7)                  0.998
   Diabetes mellitus                                                           32 (13.7)                   30 (13.1)                  0.856
   Heart failure                                                               23 (9.8)                    27 (11.8)                  0.497
   End stage renal disease                                                     21 (9.0)                    24 (10.5)                  0.584
   Liver cirrhosis                                                             12 (5.1)                    16 (7.0)                   0.402
   Solid organ transplant                                                      15 (6.4)                    11 (4.8)                   0.453
   Bronchiectasis                                                              8 (3.4)                     8 (3.5)                    0.965
  Transferred from other ICU                                                   48 (20.5)                   39 (17.0)                  0.333
  Mechanical ventilator applied                                                168 (71.8)                  146 (63.8)                 0.064
   Ventilator day^[a](#tfn1-acc-2018-00220){ref-type="table-fn"}^              5 (3--9)                    4 (2--8)                   0.120
  Use of antacids                                                              207 (88.5)                  199 (86.9)                 0.609
  Use of steroids                                                              133 (56.8)                  118 (51.5)                 0.252
   Steroid day^[a](#tfn1-acc-2018-00220){ref-type="table-fn"}^                 4 (2--8)                    4 (2--7)                   0.883
  No. of respiratory samples^[b](#tfn2-acc-2018-00220){ref-type="table-fn"}^   530.5 (488.2--572.8)        513.5 (468.6--558.5)       0.588

Value are presented as number (%) or median (interquartile range) unless otherwise indicated.

ICU: intensive care unit; APACHE: Acute Physiology and Chronic Health Evaluation.

Calculated as calendar days;

Presented as incidence rate per 1,000 patient-days (95% confidence interval).

###### 

Differences in clinical outcomes before and after the MICU relocation

  Variable                                                   Before relocation (n=234)   After relocation (n=229)   P-value
  ---------------------------------------------------------- --------------------------- -------------------------- ---------
  MICU day^[a](#tfn3-acc-2018-00220){ref-type="table-fn"}^   6 (3--10)                   5 (2--9)                   0.145
  Hospital day^a^                                            29 (14--50)                 21 (11--39)                0.001
  In-hospital mortality                                      126 (52.5)                  114 (47.5)                 0.382

Values are presented as median (interquartile range) or number (%).

MICU: medical intensive care unit.

Calculated as calendar days.
